Notable Quotes
"About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP). Our findings support the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications."